Athira Pharma

Seattle, United States

Athira Pharma is a clinical stage drug development company that specializes in biotechnology and pharmaceutical.

Dec 2025

Post-IPO Equity

Biotechnology Pharmaceutical Therapeutics

Top Investors

Franklin TempletonJanus Henderson InvestorsPerceptive AdvisorsTCG CrossoverSofinnova Investments

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Athira Pharma

Who are Athira Pharma's investors?

Athira Pharma's investors include Franklin Templeton, Janus Henderson Investors, Perceptive Advisors, TCG Crossover, Sofinnova Investments.

Where is Athira Pharma headquartered?

Athira Pharma is headquartered in Seattle, United States.

What does Athira Pharma do?

Athira Pharma is a clinical stage drug development company that specializes in biotechnology and pharmaceutical.

What stage is Athira Pharma at?

Athira Pharma is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated December 18, 2025.

MLA

"Athira Pharma — Funding & Investors." VCBacked, December 18, 2025, https://www.vcbacked.co/company/athira-pharma. Accessed July 1, 2026.

APA

VCBacked. (2025). Athira Pharma — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/athira-pharma

Wikipedia (cite web)

{{cite web |title=Athira Pharma — Funding & Investors |url=https://www.vcbacked.co/company/athira-pharma |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated December 18, 2025.

Similar Companies in Biotechnology

View all

Renaissance BioScience

Vancouver

Rapport Therapeutics

Boston

Neuroglee Therapeutics

Singapore

Living In Silico Inc.